Over the past 12 months, 8 insiders at NovoCure Ltd filed 20 open-market SEC Form 4 transactions on NVCR: 3 purchases worth $1.2M and 17 sales worth $2.3M. Insiders have been net sellers over this period. The most recent filing was on Mar 5, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 5, 26 | Mukund ParavasthuChief Operating Officer | SELL | 43.2K | $13.77 | $595K |
| Mar 4, 26 | Nicolas LeupinFormer Chief Medical Officer | SELL | 1.1K | $13.31 | $15K |
| Mar 4, 26 | Christoph BrackmannChief Financial Officer | SELL | 6.4K | $13.31 | $85K |
| Mar 4, 26 | Frank X LeonardChief Executive Officer | SELL | 5.6K | $13.31 | $75K |
| Mar 4, 26 | Mukund ParavasthuChief Operating Officer | SELL | 5.4K | $13.31 | $72K |
| Mar 4, 26 | Michal Nath PuriChief Human Resources Officer | SELL | 1.1K | $13.31 | $15K |
| Mar 4, 26 | Uri WeinbergChf Medical and Innovation Ofr | SELL | 6.4K | $13.31 | $85K |
| Mar 3, 26 | William F DoyleExecutive Chairman | SELL | 50.6K | $13.43 | $647K |
| Mar 2, 26 | Frank X LeonardChief Executive Officer | SELL | 7.2K | $13.49 | $98K |
| Mar 2, 26 | Mukund ParavasthuChief Operating Officer | SELL | 408 | $13.49 | $6K |
| Mar 2, 26 | Uri WeinbergChf Medical and Innovation Ofr | SELL | 3.3K | $13.33 | $44K |
| Feb 27, 26 | Frank X LeonardChief Executive Officer | SELL | 9.7K | $13.66 | $133K |
| Feb 27, 26 | Nicolas LeupinFormer Chief Medical Officer | SELL | 1.0K | $13.66 | $14K |
| Feb 27, 26 | Mukund ParavasthuChief Operating Officer | SELL | 1.6K | $13.66 | $21K |
| Feb 27, 26 | Michal Nath PuriChief Human Resources Officer | SELL | 1.4K | $13.66 | $20K |
| Feb 27, 26 | Uri WeinbergChf Medical and Innovation Ofr | SELL | 7.5K | $13.84 | $103K |
| Sep 5, 25 | Ashley CordovaChief Executive Officer | BUY | 81.5K | $12.22 | $997K |
| Jul 29, 25 | Christoph BrackmannChief Financial Officer | BUY | 10.0K | $11.63 | $116K |
| Jun 3, 25 | Jeryl L HillemanDirector | SELL | 999 | $17.26 | $17K |
| Jun 3, 25 | David HungDirector | SELL | 999 | $17.30 | $17K |
| Jun 3, 25 | Gabriel LeungDirector | SELL | 999 | $17.31 | $17K |
| Jun 3, 25 | Martin J. MaddenDirector | SELL | 999 | $17.19 | $17K |
| Jun 3, 25 | Allyson J OceanDirector | SELL | 999 | $17.29 | $17K |
| Jun 3, 25 | Timothy J ScannellDirector | SELL | 999 | $17.32 | $17K |
| Jun 3, 25 | Kristin StaffordDirector | SELL | 999 | $17.28 | $17K |
| Jun 3, 25 | W Anthony VernonDirector | SELL | 999 | $17.35 | $17K |
| Jun 2, 25 | Frank X LeonardEVP, Pres., Novocure Oncology | SELL | 21.7K | $19.01 | $374K |
| May 3, 25 | Mukund ParavasthuChief Operating Officer | SELL | 592 | $17.91 | $11K |
| Mar 3, 25 | Ashley CordovaChief Executive Officer | SELL | 2.1K | $18.54 | $38K |
| Mar 3, 25 | Frank X LeonardEVP, Pres., Novocure Oncology | SELL | 2.5K | $18.54 | $47K |
| Mar 3, 25 | Mukund ParavasthuChief Operating Officer | SELL | 250 | $18.54 | $5K |
| Mar 3, 25 | Uri WeinbergChief Innovation Officer | SELL | 268 | $18.92 | $5K |
| Feb 28, 25 | Uri WeinbergChief Innovation Officer | SELL | 4.3K | $18.78 | $81K |
| Feb 28, 25 | Ashley CordovaChief Executive Officer | SELL | 2.3K | $18.28 | $43K |
| Feb 28, 25 | Frank X LeonardEVP, Pres., Novocure Oncology | SELL | 2.8K | $18.28 | $51K |
| Feb 28, 25 | Mukund ParavasthuChief Operating Officer | SELL | 368 | $18.28 | $7K |
| Feb 27, 25 | Ashley CordovaChief Executive Officer | SELL | 9.3K | $20.55 | $186K |
| Feb 27, 25 | Frank X LeonardEVP, Pres., Novocure Oncology | SELL | 10.3K | $20.55 | $205K |
| Feb 27, 25 | Nicolas LeupinChief Medical Officer | SELL | 830 | $20.55 | $17K |
| Feb 27, 25 | Mukund ParavasthuChief Operating Officer | SELL | 1.4K | $20.55 | $27K |
| Feb 27, 25 | Michal Nath PuriChief Human Resources Officer | SELL | 1.2K | $20.55 | $23K |
| Jan 11, 25 | Mukund ParavasthuChief Operating Officer | SELL | 2.2K | $26.81 | $58K |
| Nov 2, 24 | Mukund ParavasthuChief Operating Officer | SELL | 44 | $16.69 | $734 |
| Nov 1, 24 | Frank X LeonardEVP, Pres., Novocure Oncology | SELL | 598 | $15.94 | $10K |
| Nov 1, 24 | Mukund ParavasthuChief Operating Officer | SELL | 160 | $15.88 | $3K |
| Oct 31, 24 | Michal Nath PuriChief Human Resources Officer | SELL | 810 | $15.79 | $13K |
| Aug 2, 24 | Ashley CordovaChief Financial Officer | SELL | 688 | $20.14 | $14K |
| Jun 4, 24 | Gabriel LeungDirector | SELL | 964 | $23.89 | $23K |
| Jun 4, 24 | Timothy J ScannellDirector | SELL | 964 | $23.89 | $23K |
| Jun 4, 24 | W Anthony VernonDirector | SELL | 964 | $23.89 | $23K |
Over the past 12 months, insiders at NovoCure Ltd filed 3 open-market purchases worth $1.2M and 17 sales worth $2.3M on NVCR, which makes them net sellers over the period. The most recent Form 4 was filed on Mar 5, 26.
The largest recent open-market NVCR insider purchase in our data was $997K by Ashley Cordova, Chief Executive Officer, filed on Sep 5, 25.
8 different insiders at NovoCure Ltd filed open-market SEC Form 4 transactions on NVCR over the last 12 months.
InsiderTape plots every NVCR insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every NovoCure Ltd insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →